Project
Personalisierung der Blasenkrebstherapie anhand von Unterschieden im Mikrobiom der Blase und von Stuhlproben
Automatically Closed · 2023 until 2024
Engeler Daniel, Langenauer Janine, Lyatoshinsky Pavel, Patzl Sigrid, Zürn Karin
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2023
End Date
2024
Financing
Others
Labels
bladder cancer
Brief description/objective
Towards individualization of bladder cancer therapy: the role
of microbiome in BCG responsiveness prediction